Inhibition of proliferation and migration of tumor cells through phenylboronic acid-functionalized polyamidoamine-mediated delivery of a therapeutic DNAzyme Dz13

References

• Kankala RK, Liu CG, Chen AZ, et al. Overcoming multidrug resistance through the synergistic effects of hierarchical pH-sensitive, ROS-generating nanoreactors. ACS Biomater Sci Eng. 2017;3:2431–2442. doi:10.1021/acsbiomaterials.7b00569
   PubMed Web of Science ®Google Scholar
• Chen BQ, Kankala RK, He GY, et al. Supercritical fluid-assisted fabrication of indocyanine green-encapsulated silk fibroin nanoparticles for dual-triggered cancer therapy. ACS Biomater Sci Eng. 2018;4:3487–3497. doi:10.1021/acsbiomaterials.8b00705
   PubMed Web of Science ®Google Scholar
• Xu PY, Kankala RK, Pan YJ, et al. Overcoming multidrug resistance through inhalable siRNA nanoparticles-decorated porous microparticles based on supercritical fluid technology. Int J Nanomed. 2018;13:4685–4698. doi:10.2147/IJN.S169399
   PubMed Web of Science ®Google Scholar
• Liu CG, Han YH, Zhang JT, et al. Rerouting engineered metal-dependent shapes of mesoporous silica nanocontainers to biodegradable Janus-type (sphero-ellipsoid) nanoreactors for chemodynamic therapy. Chem Eng J. 2019;370:1188–1199. doi:10.1016/j.cej.2019.03.272
   Web of Science ®Google Scholar
• Vile RG, Russell SJ, Lemoine N. Cancer gene therapy: hard lessons and new courses. Gene Ther. 2000;7:2–8. doi:10.1038/sj.gt.330108410680008
   PubMed Web of Science ®Google Scholar
• Lin S, Gregory RI. MicroRNA biogenesis pathways in cancer. Nat Rev Cancer. 2015;15:321–333. doi:10.1038/nrc393225998712
   PubMed Web of Science ®Google Scholar
• Naldini L. Gene therapy returns to centre stage. Nature. 2015;526:351–360. doi:10.1038/nature1581826469046
   PubMed Web of Science ®Google Scholar
• Wirth T, Parker N, Yla-Herttuala S. History of gene therapy. Gene. 2013;525:162–169. doi:10.1016/j.gene.2013.03.13723618815
   PubMed Web of Science ®Google Scholar
• Wu P, Hwang K, Lan T, et al. A DNAzyme-gold nanoparticle probe for uranyl ion in living cells. J Am Chem Soc. 2013;135:5254–5257. doi:10.1021/ja400150v23531046
   PubMed Web of Science ®Google Scholar
• Liu H, Yu X, Chen Y, et al. Crystal structure of an RNA-cleaving DNAzyme. Nat Commun. 2017;8:2006. doi:10.1038/s41467-017-02203-x29222499
   PubMed Web of Science ®Google Scholar
• Khachigian LM. Deoxyribozymes as catalytic nanotherapeutic agents. Cancer Res. 2019;79:879–888. doi:10.1158/0008-5472.CAN-18-247430760521
   PubMedGoogle Scholar
• Xing Z, Gao S, Duan Y, et al. Delivery of DNAzyme targeting aurora kinase A to inhibit the proliferation and migration of human prostate cancer. Int J Nanomed. 2015;10:5715–5727. doi:10.2147/IJN.S90559.
   PubMed Web of Science ®Google Scholar
• Elahy M, Dass CR. Dz13: c-Jun downregulation and tumour cell death. Chem Biol Drug Des. 2011;78:909–912. doi:10.1111/j.1747-0285.2011.01166.x.21722318
   PubMed Web of Science ®Google Scholar
• Kim SH, Dass CR. Induction of caspase-2 activation by a DNA enzyme evokes tumor cell apoptosis. DNA Cell Biol. 2012;31:1–7. doi:10.1089/dna.2011.132322077397
   PubMed Web of Science ®Google Scholar
• Dass CR, Galloway SJ, Choong PF. Dz13, a c-jun DNAzyme, is a potent inducer of caspase-2 activation. Oligonucleotides. 2010;20:137–146. doi:10.1089/oli.2009.022620180631
   PubMed Web of Science ®Google Scholar
• Meng L, Ma W, Lin S, et al. Tetrahedral DNA nanostructure-delivered DNAzyme for gene silencing to suppress cell growth. ACS Appl Mater Interfaces. 2019;11:6850–6857. doi:10.1021/acsami.8b2244430698411
   PubMed Web of Science ®Google Scholar
• Eicher AC, Dobler D, Kiselmann C, et al. Dermal delivery of therapeutic DNAzymes via chitosan hydrogels. Int J Pharm. 2019. doi:10.1016/j.ijpharm.2019.04.005
   PubMedGoogle Scholar
• Pouton CW, Seymour LW. Key issues in non-viral gene delivery. Adv Drug Deliv Rev. 2001;46:187–203. doi:10.1016/S0169-409X(00)00133-211259840
   PubMed Web of Science ®Google Scholar
• El-Aneed A. An overview of current delivery systems in cancer gene therapy. J Control Release. 2004;94:1–14. doi:10.1016/j.jconrel.2003.09.01314684267
   PubMed Web of Science ®Google Scholar
• Zhang J, Wu D, Xing Z, et al. N-Isopropylacrylamide-modified polyethylenimine-mediated p53 gene delivery to prevent the proliferation of cancer cells. Colloids Surf B Biointerfaces. 2015;129:54–62. doi:10.1016/j.colsurfb.2015.03.03225829127
   PubMed Web of Science ®Google Scholar
• Lee CC, MacKay JA, Frechet JM, et al. Designing dendrimers for biological applications. Nat Biotechnol. 2005;23:1517–1526. doi:10.1038/nbt117116333296
   PubMed Web of Science ®Google Scholar
• Majoros IJ, Myc A, Thomas T, et al. PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality. Biomacromolecules. 2006;7:572–579. doi:10.1021/bm050614216471932
   PubMed Web of Science ®Google Scholar
• Han H, Chen W, Yang J, et al. 2-Amino-6-chloropurine-modified polyamidoamine-mediated p53 gene transfection to achieve anti-tumor efficacy. New J Chem. 2018;42:13375–13381. doi:10.1039/C8NJ01870G
   Web of Science ®Google Scholar
• Zhou J, Wu J, Hafdi N, et al. PAMAM dendrimers for efficient siRNA delivery and potent gene silencing. Chem Commun. 2006;22:2362–2364. doi:10.1039/b601381c
   PubMed Web of Science ®Google Scholar
• Wang M, Cheng Y. The effect of fluorination on the transfection efficacy of surface-engineered dendrimers. Biomaterials. 2014;35:6603–6613. doi:10.1016/j.biomaterials.2014.04.06524818889
   PubMed Web of Science ®Google Scholar
• Wang M, Liu H, Li L, et al. A fluorinated dendrimer achieves excellent gene transfection efficacy at extremely low nitrogen to phosphorus ratios. Nat Commun. 2014;5:3053. doi:10.1038/ncomms597224407172
   PubMed Web of Science ®Google Scholar
• Wang H, Wei H, Huang Q, et al. Nucleobase-modified dendrimers as nonviral vectors for efficient and low cytotoxic gene delivery. Colloids Surf B Biointerfaces. 2015;136:1148–1155. doi:10.1016/j.colsurfb.2015.11.01526613860
   PubMedGoogle Scholar
• Han H, Yang J, Wang Y, et al. Nucleobase-modified polyamidoamine-mediated miR-23b delivery to inhibit the proliferation and migration of lung cancer. Biomater Sci. 2017;5:2268–2275. doi:10.1039/c7bm00599g28976503
   PubMedGoogle Scholar
• Choi JS, Nam K, Park JY, et al. Enhanced transfection efficiency of PAMAM dendrimer by surface modification with L-arginine. J Control Release. 2004;99:445–456. doi:10.1016/j.jconrel.2004.07.02715451602
   PubMed Web of Science ®Google Scholar
• Iacobazzi RM, Porcelli L, Lopedota AA, et al. Targeting human liver cancer cells with lactobionic acid-G (4)-PAMAM-FITC sorafenib loaded dendrimers. Int J Pharm. 2017;528:485–497. doi:10.1016/j.ijpharm.2017.06.04928624661
   PubMed Web of Science ®Google Scholar
• Chen W, Liu Y, Liang X, et al. Chondroitin sulfate-functionalized polyamidoamine as a tumor-targeted carrier for miR-34a delivery. Acta Biomater. 2017;57:238–250. doi:10.1016/j.actbio.2017.05.03028511876
   PubMed Web of Science ®Google Scholar
• Jiang LY, Lv B, Luo Y. The effects of an RGD-PAMAM dendrimer conjugate in 3D spheroid culture on cell proliferation, expression and aggregation. Biomaterials. 2013;34:2665–2673. doi:10.1016/j.biomaterials.2013.01.00323340194
   PubMed Web of Science ®Google Scholar
• Wu D, Yang J, Xing Z, et al. Phenylboronic acid-functionalized polyamidoamine-mediated Bcl-2 siRNA delivery for inhibiting the cell proliferation. Colloids Surf B Biointerfaces. 2016;146:318–325. doi:10.1016/j.colsurfb.2016.06.03427371891
   PubMed Web of Science ®Google Scholar
• Deshayes S, Cabral H, Ishii T, et al. Phenylboronic acid-installed polymeric micelles for targeting sialylated epitopes in solid tumors. J Am Chem Soc. 2013;135:15501–15507. doi:10.1021/ja406406h24028269
   PubMed Web of Science ®Google Scholar
• Matsumoto A, Cabral H, Sato N, et al. Assessment of tumor metastasis by the direct determination of cell‐membrane sialic acid expression. Angew Chem Int Ed. 2010;49:5494–5497. doi:10.1002/anie.201001220
   PubMed Web of Science ®Google Scholar
• Song Z, Liang X, Wang Y, et al. Phenylboronic acid-functionalized polyamidoamine-mediated miR-34a delivery for the treatment of gastric cancer. Biomater Sci. 2019;7:1632–1642. doi:10.1039/c8bm01385c30720809
   PubMed Web of Science ®Google Scholar
• Yang J, Zhang J, Liu Y, et al. Phenylboronic acid-modified polyamidoamine-mediated delivery of short GC rich DNA for hepatocarcinoma gene therapy. Biomater Sci. 2019;7:3348–3358. doi:10.1039/C9BM00394K31218303
   PubMedGoogle Scholar
• Yang TJ, Haimovitz-Friedman A, Verheij M. Anticancer therapy and apoptosis imaging. Exp Oncol. 2012;34:269–276.23070012
   PubMedGoogle Scholar
• Dong M, Chen J, Zhang J, et al. A chemoenzymatically synthesized cholesterol-g-poly(amine-co-ester)-mediated p53 gene delivery for achieving antitumor efficacy in prostate cancer. Int J Nanomed. 2019;14:1149–1161. doi:10.2147/IJN.S191905
   PubMed Web of Science ®Google Scholar
• Wang Y, Li H, Li Y, et al. Identification of natural compounds targeting Annexin A2 with an anti-cancer effect. Protein Cell. 2018;9:568–579. doi:10.1007/s13238-018-0513-z29508276
   PubMedGoogle Scholar
• Tan ML, Choong PF, Dass CR. Direct anti-metastatic efficacy by the DNA enzyme Dz13 and downregulated MMP-2, MMP-9 and MT1-MMP in tumours. Cancer Cell Int. 2010;10:9. doi:10.1186/1475-2867-10-920334687
   PubMedGoogle Scholar